Back
Oragenics, Inc. 10K Form
Sell
21
OGEN
Oragenics, Inc.
Last Price:
$0.86
Seasonality Move:
6.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-04 | 10K | OGEN/Oragenics, Inc. Annual |
| 2019-11-14 | 10Q | OGEN/Oragenics, Inc. Quarterly |
| 2019-08-14 | 10Q | OGEN/Oragenics, Inc. Quarterly |
| 2019-05-13 | 10Q | OGEN/Oragenics, Inc. Quarterly |
| 2019-04-29 | 10K | OGEN/Oragenics, Inc. Annual |
| 2019-03-29 | 10K | OGEN/Oragenics, Inc. Annual |
Receive OGEN News And Ratings
See the #1 stock for the next 7 days that we like better than OGEN
OGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.38 |
| Price / Book: | 0.07 |
Profitability
| EPS (TTM): | -13.18410 |
|---|---|
| Net Income (TTM): | $-10.9M |
| Gross Margin: | $0 |
| Return on Equity: | -509.23% |
| Return on Assets: | -214.74% |
Oragenics, Inc. Earnings Forecast
Key Oragenics, Inc. Financial Ratios
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Oragenics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OGEN |
| CUSIP: | 684023 |
| Website: | oragenics.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 4.42 |
| Quick Ratio: | 3.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
OGEN Technical Analysis vs Fundamental Analysis
Sell
21
Oragenics, Inc. (OGEN)
is a Sell
Is Oragenics, Inc. a Buy or a Sell?
-
Oragenics, Inc. stock is rated a SellThe current Oragenics, Inc. [OGEN] share price is $0.86. The Score for OGEN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.